MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway
R.-S. Wu, E.-H. Qiu, J.-J. Zhu, J.-R. Wang, H.-L. Lin Department of Otolaryngology, the 2nd Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
The article “MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway, by R.-S. Wu, E.-H. Qiu, J.-J. Zhu, J.-R. Wang, H.-L. Lin, published in Eur Rev Med Pharmacol Sci 2018; 22(1): 150-157–DOI: 10.26355/eurrev_201801_14112–PMID: 29364482” has been withdrawn from the authors.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/14112
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
R.-S. Wu, E.-H. Qiu, J.-J. Zhu, J.-R. Wang, H.-L. Lin
MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 16
Pages: 8240-8240
DOI: 10.26355/eurrev_202008_22580